Cargando…

Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs

The pharmacological treatment of epilepsy is purely symptomatic. Despite many decades of intensive research, causal treatment of this common neurologic disorder is still unavailable. Nevertheless, it is expected that advances in modern neuroscience and molecular biology tools, as well as improved an...

Descripción completa

Detalles Bibliográficos
Autores principales: Łukasiuk, Katarzyna, Lasoń, Władysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917847/
https://www.ncbi.nlm.nih.gov/pubmed/36769250
http://dx.doi.org/10.3390/ijms24032928